Eliminating radiotherapy to the contralateral retropharyngeal and high level II lymph nodes in head and neck squamous cell carcinoma is safe and improves quality of life

Publisher： Blackwell Publishing

E-ISSN： 1097-0142|120|24|3994-4002

ISSN： 0008-543X

Source： Cancer, Vol.120, Iss.24, 2014-12, pp. : 3994-4002

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase II study of sunitinib malate in head and neck squamous cell carcinoma

By Choong Nicholas   Kozloff Mark   Taber David   Hu H.   Wade James   Ivy Percy   Karrison Theodore   Dekker Allison   Vokes Everett   Cohen Ezra  

Investigational New Drugs, Vol. 28, Iss. 5, 2010-10 ,pp. : 677-683

Springer Publishing Company

Access to resources Recommend Favorite

Pharmacotherapy for squamous-cell carcinoma of the head and neck

By Papaspyrou Giorgos   Werner Jochen A   Dietz Andreas  

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 3, 2011-02 ,pp. : 397-409

Informa Healthcare

Access to resources Recommend Favorite

Afatinib in the treatment of head and neck squamous cell carcinoma

By Ferrarotto Renata   Gold Kathryn A  

Expert Opinion on Investigational Drugs, Vol. 23, Iss. 1, 2014-01 ,pp. : 135-143

Informa Healthcare

Access to resources Recommend Favorite

Progress in Immunotherapy of Head and Neck Squamous Cell Carcinoma

By  

Current Molecular Pharmacology, Vol. 9, Iss. 3, 2016-08 ,pp. : 226-230

Bentham Science Publishers

Access to resources Recommend Favorite

Cisplatin + capecitabine active in head, neck squamous cell carcinoma

By  

Inpharma, Vol. 1, Iss. 1475, 2005-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite